Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

被引:187
作者
Millan, MJ [1 ]
Lejeune, F [1 ]
Gobert, A [1 ]
机构
[1] Ctr Rech Croissy, Inst Rech Servier, Dept Psychopharmacol, F-78290 Croissy Sur Seine, France
关键词
antidepressant; depression; dopamine; frontal cortex; monoamines; mood; noradrenaline; selective serotonin reuptake inhibitor; serotonin; tricyclic;
D O I
10.1177/026988110001400202
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The frontal cortex (FCX) plays a key role in processes that control mood, cognition and motor behaviour, functions which are compromised in depression, schizophrenia and other psychiatric disorders. In this regard, there is considerable evidence that a perturbation of monoaminergic input to the FCX is involved in the pathogenesis of these states. Correspondingly, the modulation of monoaminergic transmission in the FCX and other corticolimbic structures plays an important role in the actions of antipsychotic and antidepressant agents. In order to further understand the significance of monoaminergic systems in psychiatric disorders and their treatment, it is essential to characterize mechanisms underlying their modulation. Within this framework, the present commentary focuses on our electrophysiological and dialysis analyses of the complex and reciprocal pattern of auto- and heteroreceptor mediated control of dopaminergic, noradrenergic and serotonergic transmission in the FCX. The delineation of such interactions provides a framework for an interpretation of the influence of diverse classes of antidepressant agent upon extracellular levels of dopamine, noradrenaline and serotonin in FCX. Moreover, it also generates important insights into strategies for the potential improvement in the therapeutic profiles of antidepressant agents.
引用
收藏
页码:114 / 138
页数:25
相关论文
共 386 条
[71]   EVIDENCE THAT 5-HYDROXYTRYPTAMINE RELEASE IN RAT DORSAL RAPHE NUCLEUS IS CONTROLLED BY 5-HT1A, 5-HT1B AND 5-HT1D AUTORECEPTORS [J].
DAVIDSON, C ;
STAMFORD, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) :1107-1109
[72]   Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex [J].
Dawson, LA ;
Nguyen, HQ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 345 (01) :41-46
[73]  
De Deurwaerdère P, 1998, J NEUROSCI, V18, P6528
[74]   Role of serotonin2A and serotonin2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation [J].
De Deurwaerdère, P ;
Spampinato, U .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1033-1042
[75]   5-HT, antidepressant drugs and the psychosocial origins of depression [J].
Deakin, JFW .
JOURNAL OF PSYCHOPHARMACOLOGY, 1996, 10 (01) :31-38
[76]   Serotonergic synergism: The risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs [J].
DeBattista, C ;
Sofuoglu, M ;
Schatzberg, AF .
BIOLOGICAL PSYCHIATRY, 1998, 44 (05) :341-347
[77]  
deBoer T, 1996, J PHARMACOL EXP THER, V277, P852
[78]   Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens [J].
Di Matteo, V ;
Di Giovanni, G ;
Di Mascio, M ;
Esposito, E .
NEUROPHARMACOLOGY, 1998, 37 (02) :265-272
[79]  
DIAZ J, 1995, NEUROSCIENCE, V65, P731, DOI 10.1016/0306-4522(94)00527-C
[80]  
DICKINSON SL, 1991, DRUG NEWS PERSPECT, V4, P197